Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Bensa

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Presse Medicale (Paris, France : 1983)|March 22, 1986
[Malignant non-Hodgkin's lymphoma associated with a serum monoclonal immunoglobulin]J J Sotto, A Rueff, J C Bensa, et al.
Immunology|January 1, 1984
Role of C3 in the control of monocyte C2 productionA O Hamilton, L Morrison, W S Kilpatrick, et al.
Archives Francaises De Pediatrie|August 1, 1983
[Erythroblastopenia in a child with immune deficiency and hyper IgM]C Bachelot, P François, M Bost, et al.
European Journal of Immunology|December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.
Transplantation|November 27, 1996
False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsoleteA Pierquin, D Masson, O Toupance, et al.
Experimental Hematology|March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.
American Journal of Hematology|January 1, 1992
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD)M C Jacob, M Favre, F Lemarc'Hadour, et al.
Cytotherapy|June 19, 2004
Preparation of purified lymphoma cells suitable for therapyG Lui, O Manches, L Chaperot, et al.
Blood|March 1, 1990
T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant cloneM C Jacob, M P Piccinni, T Bonnefoix, et al.
Vox Sanguinis|January 1, 1996
HCV-Infection in blood donors: association between anti-HCV core IgM antibodies and serum HCV RNAA Ounanian-Paraz, C Morel-Baccard, V Barlet, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Presse Medicale (Paris, France : 1983)|March 22, 1986
[Malignant non-Hodgkin's lymphoma associated with a serum monoclonal immunoglobulin]J J Sotto, A Rueff, J C Bensa, et al.
Immunology|January 1, 1984
Role of C3 in the control of monocyte C2 productionA O Hamilton, L Morrison, W S Kilpatrick, et al.
Archives Francaises De Pediatrie|August 1, 1983
[Erythroblastopenia in a child with immune deficiency and hyper IgM]C Bachelot, P François, M Bost, et al.
European Journal of Immunology|December 1, 1995
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80 (B7-1) and CD86 (B7-2) in stimulation by tumor cellsJ Plumas, L Chaperot, M C Jacob, et al.
Transplantation|November 27, 1996
False-negative results in anti-HLA antibody detection by Sangstat ELISA: complement dependent cytotoxicity is not yet obsoleteA Pierquin, D Masson, O Toupance, et al.
Experimental Hematology|March 25, 1999
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomasL Chaperot, J Plumas, M C Jacob, et al.
American Journal of Hematology|January 1, 1992
CD45RA expression by CD4 T lymphocytes in tumors invaded by B-cell non-Hodgkin's lymphoma (NHL) or Hodgkin's disease (HD)M C Jacob, M Favre, F Lemarc'Hadour, et al.
Cytotherapy|June 19, 2004
Preparation of purified lymphoma cells suitable for therapyG Lui, O Manches, L Chaperot, et al.
Blood|March 1, 1990
T lymphocytes from invaded lymph nodes in patients with B-cell-derived non-Hodgkin's lymphoma: reactivity toward the malignant cloneM C Jacob, M P Piccinni, T Bonnefoix, et al.
Vox Sanguinis|January 1, 1996
HCV-Infection in blood donors: association between anti-HCV core IgM antibodies and serum HCV RNAA Ounanian-Paraz, C Morel-Baccard, V Barlet, et al.
Pageof 7